Pricing Log in Create free account

IO Biotech, Inc. (IOBTQ) vs Nuvilex Inc. (PMCB)

IO Biotech, Inc. and Nuvilex Inc. are both Biotechnology companies. Nuvilex Inc. is the larger, with a market value of $3.8M against $3.5M — 1.1× the size. Across the 10 metrics below, IO Biotech, Inc. leads on 5 and Nuvilex Inc. on 5.

Valuation

Metric IOBTQ PMCB Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 3.82 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% (679.41%) (33.15%)
Free cash flow yield 0.00% (290.03%) (25.50%)

Profitability

Metric IOBTQ PMCB Biotechnology median
Gross margin 0.00% 95.64% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (240.48%) (58.04%) (56.36%)
Return on assets (136.03%) (50.43%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IOBTQ PMCB Biotechnology median
Revenue growth (TTM) — (71.06%) 6.02%
EPS growth (last fiscal year) 26.77% (186.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IOBTQ PMCB Biotechnology median
Debt to equity 18.29 0.00 0.00
Current ratio 2.01 40.29 4.72
Net debt to EBITDA 0.63 5.41 0.96

Dividend

Metric IOBTQ PMCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IOBTQ PMCB Biotechnology median
Market cap 3.45m 3.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack